Clinical Trials Related to Hoffmann-La Roche

Related studies linked through entity extraction aliases.

Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer

Status: COMPLETED
Phase: PHASE3

A Non-Interventional Study in Patients With Moderate to Severe Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)

Status: COMPLETED
Phase: N/A

A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer

Status: COMPLETED
Phase: PHASE3

An Observational Study of Avastin (Bevacizumab) in Combination With Paclitaxel in First-Line Treatment in Patients With HER2-Negative Metastatic Breast Cancer

Status: COMPLETED
Phase: N/A

A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage

Status: TERMINATED
Phase: PHASE4

PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

Status: COMPLETED
Phase: N/A

A Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Participants With Hepatitis C

Status: COMPLETED
Phase: N/A

GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma

Status: TERMINATED
Phase: PHASE3

Accu-Chek Combo in Young Patients

Status: COMPLETED
Phase: N/A

A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis

Status: COMPLETED
Phase: PHASE3

A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy Volunteers

Status: COMPLETED
Phase: PHASE1

Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery

Status: COMPLETED
Phase: PHASE2

A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma

Status: COMPLETED
Phase: PHASE3

A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II)

Status: COMPLETED
Phase: N/A

A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid Arthritis

Status: COMPLETED
Phase: PHASE3

A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265

Status: COMPLETED
Phase: N/A

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)

Status: TERMINATED
Phase: N/A

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent

Status: COMPLETED
Phase: N/A

A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

Status: TERMINATED
Phase: PHASE2/PHASE3

A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia

Status: COMPLETED
Phase: PHASE1